JOYCE ORTIZ: Open Payments
NPI 1619208121 · BOSTON, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$562 in 6 payments from 5 companies in 2025. Trend: 2023 $0 · 2024 $251 · 2025 $562
Food & beverage: $562
| Company | Payments | Amount |
|---|---|---|
| Madrigal Pharmaceuticals | 2 | $202 |
| Janssen Biotech, Inc. | 1 | $133 |
| ABBVIE INC. | 1 | $125 |
| GENZYME CORPORATION | 1 | $60 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $42 |
Products named: REZDIFFRA, TREMFYA, SKYRIZI, ENTYVIO.
Industry payments across MA — which companies pay providers there.
